A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

Background: Small-cell lung cancer (SCLC), a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9–11 months for patients with extensive stage (EX-SCLC...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
التنسيق: Artigo
اللغة:Inglês
منشور في: Frontiers Media S.A. 2014
الموضوعات:
Oncology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196518/
https://ncbi.nlm.nih.gov/pubmed/25353007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00271
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة